Utilization of peptides as active ingredients for slimming

Details Utilization of peptides as active ingredients for slimming Utilization of peptides as active ingredients for slimming

2007-05-11

2011-10-25

Ha, Julie (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S001100, C514S021700, C530S300000, C530S329000

Reexamination Certificate

active

08044027

ABSTRACT:
A method of using proteins of the SIRT family or of polypeptide or peptide fragments of SIRT proteins as an active ingredient for slimming, alone or in combination with at least one other active agent, in a cosmetic composition or for the preparation of a pharmaceutical and/or dermatological composition. The invention also includes the use of the peptides for treatment of cellulite and/or used to decrease, eliminate or prevent excess fat beneath the skin.

REFERENCES:
patent: 4966848 (1990-10-01), Smith et al.
patent: 5223421 (1993-06-01), Smith et al.
patent: 5837218 (1998-11-01), Peers et al.
patent: 2003/0064411 (2003-04-01), Herath et al.
patent: 2858769 (2005-02-01), None
patent: 2005002527 (2005-01-01), None
Definition of derivative from http://cancerweb.ncl.ac.uk/omd/about.html, pp. 1-5. Accessed Jul. 7, 2005.
SIRT sequence from GenBank Accession No. NP—036372, p. 1. Accessed Dec. 30, 2010.
Rudinger J, “Characteristics of the amino acids as components of a peptide hormone sequence,” Peptide Hormones, JA Parsons Edition, University Park Press, Jun. 1976, pp. 1-7.
“Designing Custom Peptides,” from SIGMA Genosys, pp. 1-2. Accessed Dec. 16, 2004.
Schinzel R, Drueckes P, “The phosphate recognition site ofEscherichia colimaltodextrin phosphorylase,” FEBS, Jul. 1991, 286(1,2): 125-128.
Berendsen HJC, “A Glimpse of the Holy Grail?” Science, 1998, 282: 642-643.
Voet D, Voet JG, Biochemistry, Second Edition, John Wiley & Sons, Inc., 1995, pp. 235-241.
Ngo JT, Marks J, Karplus M, “Computational Complexity, Protein Structure Prediction, and the Levinthal Paradox,” The Protein Folding Problem and Tertiary Structure Prediction, K. Merc Jr. and S. Le Grand Edition, 1994, pp. 491-495.
Bradley CM, Barrick D, “Limits of Cooperativity in a Structurally Modular Protein: Response of the Notch Ankyrin Domain to Analogous Alanine Substitutions in Each Repeat,” J. Mol. Biol., 2002, 324: 373-386.
Porcu M et al., “The emerging therapeutic potential of sirtuin-interacting drugs: from cell death to lifespan extension”, Trends in Pharmacological Sciences, Elsevier, Haywarth, GB, vol. 26, No. 2, Feb. 2005, pp. 94-103, XP004727629.
International search report in corresponding PCT/FR2007/000803, Feb. 13, 2008.

Affiliated with

Also associated with

Rating

Utilization of peptides as active ingredients for slimming does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Utilization of peptides as active ingredients for slimming, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Utilization of peptides as active ingredients for slimming will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4298571